<DOC>
	<DOCNO>NCT00823628</DOCNO>
	<brief_summary>In treatment coronary heart disease major cause heart attack , direct mechanical treatment catheter coronary angiography , coronary balloon intervention stenting intervention mainstay therapy recent year . In procedure , investigator use contrast medium , may cause kidney toxicity especially patient underlie kidney disease decrease kidney function . The investigator intend find contrast agent less kidney toxicity catheter base treatment coronary arterial disease patient underlie decreased kidney function</brief_summary>
	<brief_title>Contrast-medium Induced Nephrotoxicity Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide</brief_title>
	<detailed_description>Iodixanol , nonionic , dimeric , iso-osmolar contrast medium ( IOCM ) , may less nephrotoxic nonionic , monomeric , low-osmolar contrast medium ( LOCMs ) high-risk patient . We compare nephrotoxicity iodixanol iopromide , nonionic , monomeric LOCM , patient renal impairment .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>patient undergo coronary catheterization creatinine clearance rate â‰¤ 60 mL/min use CockcroftGault formula pregnancy lactation receive contrast medium within 7 day study entry emergent coronary angiography acute renal failure endstage renal disease require dialysis history hypersensitivity reaction contrast medium unstable hemodynamic state cardiogenic shock , pulmonary edema need mechanical ventilation multiple myeloma parenteral use diuretic use Nacetylcysteine use metformin nonsteroidal antiinflammatory drug within 48 hour procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>